Patrick Ford

Probiomics Ltd. is an Australian biotechnology company, which develops probiotic and biomolecular technology for commercial applications in consumer health, functional foods and pharmaceutical products. The firm's activities are the development and commercialization of products containing its probiotic strain for human health benefit, and discovery of novel biotherapeutic molecules from probiotics. It also produces a practitioner-only product, Progastrim, sold to Australian naturopaths, to help stabilise and maintain an optimal intestinal flora , and which has been shown in clinical studies to assist in the management of gastrointestinal disturbances, including diarrhoea. The company was founded in 1997 and is headquartered in Gordon, Australia.

Probiomics Ltd. is an Australian biotechnology company, which develops probiotic and biomolecular technology for commercial applications in consumer health, functional foods and pharmaceutical products. The firm's activities are the development and commercialization of products containing its probiotic strain for human health benefit, and discovery of novel biotherapeutic molecules from probiotics. It also produces a practitioner-only product, Progastrim, sold to Australian naturopaths, to help stabilise and maintain an optimal intestinal flora , and which has been shown in clinical studies to assist in the management of gastrointestinal disturbances, including diarrhoea. The company was founded in 1997 and is headquartered in Gordon, Australia.

Probiomics Ltd. is an Australian biotechnology company, which develops probiotic and biomolecular technology for commercial applications in consumer health, functional foods and pharmaceutical products. The firm's activities are the development and commercialization of products containing its probiotic strain for human health benefit, and discovery of novel biotherapeutic molecules from probiotics. It also produces a practitioner-only product, Progastrim, sold to Australian naturopaths, to help stabilise and maintain an optimal intestinal flora , and which has been shown in clinical studies to assist in the management of gastrointestinal disturbances, including diarrhoea. The company was founded in 1997 and is headquartered in Gordon, Australia.

Probiomics Ltd. is an Australian biotechnology company, which develops probiotic and biomolecular technology for commercial applications in consumer health, functional foods and pharmaceutical products. The firm's activities are the development and commercialization of products containing its probiotic strain for human health benefit, and discovery of novel biotherapeutic molecules from probiotics. It also produces a practitioner-only product, Progastrim, sold to Australian naturopaths, to help stabilise and maintain an optimal intestinal flora , and which has been shown in clinical studies to assist in the management of gastrointestinal disturbances, including diarrhoea. The company was founded in 1997 and is headquartered in Gordon, Australia.

Probiomics Ltd. is an Australian biotechnology company, which develops probiotic and biomolecular technology for commercial applications in consumer health, functional foods and pharmaceutical products. The firm's activities are the development and commercialization of products containing its probiotic strain for human health benefit, and discovery of novel biotherapeutic molecules from probiotics. It also produces a practitioner-only product, Progastrim, sold to Australian naturopaths, to help stabilise and maintain an optimal intestinal flora , and which has been shown in clinical studies to assist in the management of gastrointestinal disturbances, including diarrhoea. The company was founded in 1997 and is headquartered in Gordon, Australia.